
When a Difficult Chapter Has Ended, but the Way We Coped Continues
Editor’s Note: This article was submitted to us by Tomáš Brabec, physiotherapist and consultant for pain and chronic conditions. When pain persists, we naturally look

Editor’s Note: This article was submitted to us by Tomáš Brabec, physiotherapist and consultant for pain and chronic conditions. When pain persists, we naturally look

Key Findings from the Study Comparable Results: About 57.7% to 58% of patients receiving the omega-3 and aspirin combination achieved the main clinical treatment goal

Editor’s Note: This article is reprinted with permission from the Alliance for Clinical Trials in Oncology. Results of a national clinical trial led by the

As reported on Science Daily, a new preclinical study has revealed an unexpected link between nutrition and cancer treatment, with researchers finding that some diets

Some infections can raise a person’s risk of developing cancer. As reported on MedPage Today, global analysis estimates that about 2.3 million new cancer cases

As reported on Medical Daily, Artiva Biotherapeutics has discontinued development of its investigational autoimmune cell therapy, AlloNK, after two participant deaths occurred during a mid-stage

As reported by Science Daily, Researchers at Johns Hopkins have uncovered a long-sought explanation for how a toxin-producing gut bacterium contributes to colorectal cancer, identifying

Editor’s Note: This article was written and submitted to us by Pamela Mason, Patient Speaker & Advocate. Sometimes, the hardest part of a medical appointment

Changes in a group of genes called BAF may help cancer cells grow by altering how DNA is folded and which genes are switched on.

As reported on PharmaTimes, Merz Therapeutics has announced the completion of participant enrollment in two international Phase 3 clinical trials investigating XEOMIN (incobotulinumtoxinA) as a

AML is an aggressive cancer of the blood and bone marrow, that sometimes moves so quickly, that treatment cannot conquer it. Car-T cell therapy has

Editor’s Note: This article was written and submitted to us by Victoria Barghout, CEO and Founder Viver Health. Sixteen years ago, I was diagnosed with

As reported on ScienceDaily, researchers at the University of Virginia (UVA) have developed an experimental treatment strategy that could address two of the biggest challenges

Editor’s Note: This article was written by Wayne Eskridge, founder of the Fatty Liver Foundation. When we are diagnosed with F4 MASH (cirrhosis) we are

Editor’s Note: This story was submitted to Patient Worthy by Roger Templeman, Executive Director of Stabilize Revitalize Fort Pierce (SRFP), a grassroots nonprofit in Fort

According to recent international studies reported by MedicalXpress, the drug sac-TMT (sacituzumab tirumotecan) has been found to reduce recurrence or death from endometrial cancer. The

Calcinosis remains one of the most difficult complications to manage in patients with dermatomyositis (DM) and juvenile dermatomyositis (JDM), often causing pain, disability, and reduced

People often tell me how positive I am, and for the most part, I think that’s true. But after living with dystonia for more than
No more posts
© Copyright 2024 Patient Worthy
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
What best describes you when it comes to rare disease? (check all that apply)
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.